Viking Therapeutics
VKTX
#2409
Rank
A$9.48 B
Marketcap
$85.15
Share price
-9.14%
Change (1 day)
447.20%
Change (1 year)

Viking Therapeutics (VKTX) - Cash on Hand

Cash on Hand as of September 2024 : A$1.43 Billion

According to Viking Therapeutics 's latest financial reports the company has A$1.43 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Viking Therapeutics - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.53 B132.6%
2022-12-31A$0.22 B-18.04%
2021-12-31A$0.27 B-13.7%
2020-12-31A$0.32 B-17.95%
2019-12-31A$0.39 B-8.02%
2018-12-31A$0.42 B1524.04%
2017-12-31A$26.35 M44.46%
2016-12-31A$18.24 M-5.77%
2015-12-31A$19.36 M1996.26%
2014-12-31A$0.92 M358.65%
2013-12-31A$0.2 M
2012-12-31N/A

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.18 B-17.91%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.25 B-13.04%๐Ÿ‡บ๐Ÿ‡ธ USA